查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1469796

全球滥用药物测试市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Drugs of Abuse Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

全球滥用药物测试市场需求预计将从 2023 年的 69.9 亿美元达到 2032 年近 231.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 14.23%。

滥用药物检测是指对生物样本进行分析，以确定是否有非法药物或用于非医疗目的的处方药。进行这些测试是为了监测药物使用情况，确保遵守戒毒康復计划，并识别受药物影响的个人。采用尿液、唾液、血液和头髮检测等各种方法来筛检大麻、古柯碱、鸦片类药物、安非他明和苯二氮平类药物等药物。该测试对于执法、工作场所安全、医疗保健和成瘾治疗环境至关重要，以防止药物滥用、支持康復工作以及维护公共健康和安全。

市场动态

全球药物滥用盛行率的上升是药物滥用检测需求不断增长的主要动力。各地政府和监管机构正在实施严格的法律法规来打击药物滥用，从而促进工作场所、执法机构和康復中心采用药物检测程序。此外，人们越来越认识到药物滥用对公共健康和安全的不利影响，并鼓励雇主、教育机构和医疗机构实施常规药物检测计划。此外，药物检测技术的进步，包括快速检测试剂盒、现场护理设备和基于实验室的分析技术的开发，提高了药物滥用检测的效率、准确性和可靠性，进一步推动了市场成长。此外，扩大诊断实验室、药物检测公司和医疗保健提供者提供的药物检测服务以满足不断增长的需求有助于市场扩张。

此外，新型精神活性物质的出现和持续的鸦片类药物流行加剧了对全面、多面板药物测试解决方案的需求，推动了市场创新。此外，就业前筛检、体育组织和运输部门越来越多地采用药物检测来确保安全和遵守法规，这也刺激了市场需求。此外，对工作场所健康计划和员工健康计划的日益关注正在推动将药物测试纳入全面健康评估的一部分，进一步推动市场成长。然而，药物检测技术的进步和监管变化可能会挑战未来几年药物滥用检测市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球滥用药物测试市场的各个细分市场进行了包容性评估。滥用药物检测行业的成长和趋势为这项研究提供了整体方法。

市场区隔

滥用药物测试市场报告的这一部分提供了国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依产品类型

  • 分析仪（免疫分析仪、层析仪、呼吸分析仪）
  • 快速检测设备（尿液检测设备、口腔液检测设备）
  • 消耗品（液体收集装置、其他）

依样品类型

  • 唾液
  • 呼吸
  • 尿
  • 血
  • 头髮与汗水

按测试类型

  • 疼痛管理测试
  • 刑事司法测试
  • 工作场所筛检

按最终用户

  • 医院
  • 诊断实验室
  • 现场测试
  • 法医实验室

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲滥用药物测试市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。滥用药物测试市场的主要参与者包括美国实验室控股公司、丹纳赫公司、雅培、赛默飞世尔科技公司、罗氏公司、西门子医疗、Dragerwerk AG & Co. KGaA、岛津公司、 CareHealth America Corp . 本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：滥用药物测试 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按产品类型
    • 按样本类型进行的市场吸引力分析
    • 按测试类型进行的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球药物滥用测试市场分析：按产品类型

  • 概述：按产品类型
  • 历史和预测数据
  • 分析：依产品类型
  • 分析仪（免疫分析仪、层析仪、呼吸分析仪）
  • 快速检测设备（尿液检测设备、口腔液检测设备）
  • 消耗品（液体收集装置、其他）

第 6 章：全球药物滥用测试市场分析：按样本类型

  • 依样本类型概述
  • 历史和预测数据
  • 依样本类型分析
  • 唾液
  • 呼吸
  • 尿
  • 血
  • 头髮与汗水

第 7 章：全球滥用药物测试市场分析：按测试类型

  • 按测试类型概述
  • 历史和预测数据
  • 按测试类型分析
  • 疼痛管理测试
  • 刑事司法测试
  • 工作场所筛检

第 8 章：全球药物滥用测试市场分析：按最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医院
  • 诊断实验室
  • 现场测试
  • 法医实验室

第 9 章：全球药物滥用测试市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：滥用药物检测公司的竞争格局

  • 滥用药物测试市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Laboratory Corporation of America Holdings
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Danaher Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Abbott
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • F. Hoffmann-La Roche Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Siemens Healthineers
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Dragerwerk AG & Co. KGaA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Shimadzu Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • CareHealth America Corp.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112114183

The global demand for Drugs of Abuse Testing Market is presumed to reach the market size of nearly USD 23.15 Billion by 2032 from USD 6.99 Billion in 2023 with a CAGR of 14.23% under the study period 2024 - 2032.

Drugs of abuse testing refers to the analysis of biological samples to identify the existence of illicit drugs or prescription medications used for non-medical purposes. These tests are conducted to monitor drug use, ensure compliance with drug rehabilitation programs, and identify individuals under the influence of drugs. Various methods, such as urine, saliva, blood, and hair testing, are employed to screen for drugs like cannabis, cocaine, opioids, amphetamines, and benzodiazepines. This testing is essential in law enforcement, workplace safety, healthcare, and addiction treatment settings to prevent drug abuse, support rehabilitation efforts, and maintain public health and safety.

MARKET DYNAMICS

The rising prevalence of substance abuse globally is a major driving force behind the increasing demand for drug abuse testing. Governments and regulatory bodies across various regions are implementing stringent laws and regulations to combat drug abuse, thereby boosting the adoption of drug testing procedures in workplaces, law enforcement agencies, and rehabilitation centers. Moreover, the growing awareness regarding the detrimental effects of drug abuse on public health and safety is encouraging employers, educational institutions, and healthcare facilities to implement routine drug testing programs. Additionally, advancements in drug testing technologies, including the development of rapid testing kits, point-of-care devices, and laboratory-based analytical techniques, enhance the efficiency, accuracy, and reliability of drug abuse testing, further driving market growth. Furthermore, expanding drug testing services offered by diagnostic laboratories, drug testing companies, and healthcare providers to cater to the increasing demand contributes to market expansion.

Moreover, the emergence of new psychoactive substances and the ongoing opioid epidemic are fuelling the need for comprehensive and multi-panel drug testing solutions, driving innovation in the market. Additionally, the increasing adoption of drug testing in pre-employment screening, sports organizations, and transportation sectors to ensure safety and compliance with regulations is boosting market demand. Furthermore, the growing focus on workplace wellness programs and employee health initiatives is driving the integration of drug testing as part of comprehensive health assessments, further propelling market growth. However, advancements in drug detection technologies and regulatory changes may challenge the drug abuse testing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drugs of abuse testing. The growth and trends of drugs of abuse testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the drugs of abuse testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers)
  • Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices)
  • Consumables (Fluid Collection Devices, Others)

By Sample Type

  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat

By Testing Type

  • Pain Management Testing
  • Criminal Justice Testing
  • Workplace Screening

By End-User

  • Hospitals
  • Diagnostics Laboratories
  • On-The-Spot Testing
  • Forensic Laboratories

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drugs of Abuse Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drugs of Abuse Testing market include Laboratory Corporation of America Holdings, Danaher Corporation, Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Dragerwerk AG & Co. KGaA, Shimadzu Corporation, CareHealth America Corp. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DRUGS OF ABUSE TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Sample Type
    • 3.7.3 Market Attractiveness Analysis By Testing Type
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1 Overview by Product Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product Type
  • 5.4 Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers) Historic and Forecast Sales by Regions
  • 5.5 Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices) Historic and Forecast Sales by Regions
  • 5.6 Consumables (Fluid Collection Devices, Others) Historic and Forecast Sales by Regions

6 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY SAMPLE TYPE

  • 6.1 Overview by Sample Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Sample Type
  • 6.4 Saliva Historic and Forecast Sales by Regions
  • 6.5 Breath Historic and Forecast Sales by Regions
  • 6.6 Urine Historic and Forecast Sales by Regions
  • 6.7 Blood Historic and Forecast Sales by Regions
  • 6.8 Hair & Sweat Historic and Forecast Sales by Regions

7 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY TESTING TYPE

  • 7.1 Overview by Testing Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Testing Type
  • 7.4 Pain Management Testing Historic and Forecast Sales by Regions
  • 7.5 Criminal Justice Testing Historic and Forecast Sales by Regions
  • 7.6 Workplace Screening Historic and Forecast Sales by Regions

8 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY END-USER

  • 8.1 Overview by End-user
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-user
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Diagnostics Laboratories Historic and Forecast Sales by Regions
  • 8.6 On-the-spot Testing Historic and Forecast Sales by Regions
  • 8.7 Forensic Laboratories Historic and Forecast Sales by Regions

9 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE DRUGS OF ABUSE TESTING COMPANIES

  • 10.1. Drugs Of Abuse Testing Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF DRUGS OF ABUSE TESTING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Laboratory Corporation of America Holdings
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Danaher Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Abbott
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Thermo Fisher Scientific Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. F. Hoffmann-La Roche Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Siemens Healthineers
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Dragerwerk AG & Co. KGaA
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Shimadzu Corporation
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. CareHealth America Corp.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers) Market Sales by Geography (USD MN)
  • Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices) Market Sales by Geography (USD MN)
  • Consumables (Fluid Collection Devices, Others) Market Sales by Geography (USD MN)
  • Analysis Market by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Breath Market Sales by Geography (USD MN)
  • Urine Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Hair & Sweat Market Sales by Geography (USD MN)
  • Analysis by Testing Type (USD MN)
  • Pain Management Testing Market Sales by Geography (USD MN)
  • Criminal Justice Testing Market Sales by Geography (USD MN)
  • Workplace Screening Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostics Laboratories Market Sales by Geography (USD MN)
  • On-the-spot Testing Market Sales by Geography (USD MN)
  • Forensic Laboratories Market Sales by Geography (USD MN)
  • Global Drugs Of Abuse Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Drugs Of Abuse Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Drugs Of Abuse Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Sample Type
  • Market Attractiveness Analysis by Testing Type
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers) Market Sales by Geography (USD MN)
  • Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices) Market Sales by Geography (USD MN)
  • Consumables (Fluid Collection Devices, Others) Market Sales by Geography (USD MN)
  • Global Market Analysis by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Breath Market Sales by Geography (USD MN)
  • Urine Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Hair & Sweat Market Sales by Geography (USD MN)
  • Global Market Analysis by Testing Type (USD MN)
  • Pain Management Testing Market Sales by Geography (USD MN)
  • Criminal Justice Testing Market Sales by Geography (USD MN)
  • Workplace Screening Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostics Laboratories Market Sales by Geography (USD MN)
  • On-the-spot Testing Market Sales by Geography (USD MN)
  • Forensic Laboratories Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.